Chairman of U.S. Bishops’ Conference
Committee on Pro-Life Activities Applauds Cancellation of FDA Fetal Tissue
Contract, Urges Additional HHS Action
September 27, 2018
WASHINGTON— Cardinal Timothy Michael Dolan, Archbishop
of New York and Chairman of the U.S. Conference of Catholic Bishops (USCCB)
Committee on Pro-Life Activities, issued a statement today applauding initial
steps taken by the Secretary of Health and Human Services to terminate a Food
and Drug Administration contract to purchase aborted baby parts for research, but urging quick action
to cease all funding for research using body parts from aborted babies.
Cardinal Dolan's full statement follows:
We applaud Secretary Azar and the Administration for
cutting off ties to a company whose business is to procure aborted baby parts
for research. Not only has this company been referred for criminal
investigation by the House and Senate but using federal tax dollars for such
purposes is unethical and unacceptable.
While we are grateful for this first step, it remains
incumbent on the Administration to act quickly to cease all funding for
research involving body parts from aborted babies. The question is not
exclusively what is permitted by law, but what is right and just. For the
federal government to create a demand for abortion and use these children’s
body parts for research is wrong. We look forward to receiving answers to the
questions we and other pro-life organizations asked of Secretary Azar in our
September 11, 2018 letter regarding the funding and use of fetal tissue from
aborted babies. Under a pro-life Administration, there is simply no room for
callously using aborted children to further a research goal. This must stop
immediately. Our government should only use taxpayer dollars for ethical
research. ----
Keywords: United States Conference of Catholic
Bishops, USCCB, Cardinal Timothy Dolan, Archdiocese of New York, pro-life, HHS,
abortion
###
Media
Contact:
Judy Keane
202-541-3200